|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/085 | (2006.01) |
| A61K 39/385 | (2006.01) |
| (11) | Number of the document | 2493498 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10782040.9 |
| Date of filing the European patent application | 2010-11-01 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/IB2010/054934 |
| Date | 2010-11-01 |
| (87) | Number | WO 2011/051917 |
| Date | 2011-05-05 |
| (30) | Number | Date | Country code |
| 256905 P | 2009-10-30 | US |
| (72) |
COSTANTINO, Paolo, IT
ROMANO, Maria Rosaria, IT
BERTI, Francesco, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Staphylococcus aureus 5 tipo ir 8 tipo kapsulinių sacharidų gryninimas |
| PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES |
| Payment date | Validity (years) | Amount | |
| 2022-10-20 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-11-01 |